Related Experiment Video
Updated: Jun 5, 2026

Dual-Dye Optical Mapping of Hearts from RyR2R2474S Knock-In Mice of Catecholaminergic Polymorphic Ventricular Tachycardia
Published on: December 22, 2023
Screening of three novel candidate genes in arrhythmogenic right ventricular cardiomyopathy
Alex Hørby Christensen1, Marianne Benn, Anne Tybjærg-Hansen
1Department of Cardiology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark. alexhc@dadlnet.dk
Insights
Researchers investigated mutations in CTNNB1, CTNNA3, and PERP genes for arrhythmogenic right ventricular cardiomyopathy (ARVC). No disease-causing mutations were found in this limited cohort, suggesting other genes may be involved in ARVC pathogenesis.
Area of Science:
- Cardiology
- Genetics
- Molecular Biology
Background:
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) is linked to mutations in cellular adhesion protein genes.
- Genetic mutations explain only about 40% of ARVC cases, indicating other genetic factors are involved.
Purpose of the Study:
- To investigate the role of β-catenin (CTNNB1), α-T-catenin (CTNNA3), and PERP genes in ARVC pathogenesis.
- To screen for mutations in these intercalated disc structural proteins in ARVC patients.
Main Methods:
- Direct sequencing and LightScanner melting curve analysis were used.
- Sixty-five unrelated patients (55 fulfilling 1994 Task Force criteria, 10 borderline) were screened for mutations.
Main Results:
- No disease-causing mutations were identified in CTNNB1, CTNNA3, or PERP genes.
- Thirty-five sequence variants were detected, including one rare variant of unknown significance (CTNNA3 A689V) and 14 novel variants.
Conclusions:
- The studied genes (CTNNB1, CTNNA3, PERP) do not appear to be major contributors to ARVC in this cohort.
- Future research should explore other cardiomyocyte adhesion components in ARVC pathogenesis.
Abstract:
Arrhythmogenic right ventricular cardiomyopathy (ARVC) has been associated with mutations in genes encoding cellular adhesion proteins. However, only about 40% of patients have mutations in known genes. We hypothesized that mutations in the genes encoding β-catenin (CTNNB1), α-T-catenin (CTNNA3), and PERP (PERP)-all important structural proteins located at the intercalated disc-were involved in the pathogenesis of ARVC. We screened 65 unrelated patients (55 fulfilling 1994 Task Force criteria and ten borderline cases) for mutations in CTNNB1, CTNNA3, and PERP by direct sequencing and LightScanner melting curve analysis. Our comprehensive mutation scanning did not identify any disease-causing mutations. Thirty-five sequence variants were found, including one rare nonsynonymous variant of unknown significance (CTNNA3 A689V). Fourteen of the variants were novel. In conclusion, in our cohort of a limited size, no mutations were identified in the three studied candidate genes despite their involvement in formation and maintenance of the intercalated disk. We recommend focus on other components of cardiomyocyte adhesion in future research into the pathogenesis of ARVC.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy II: Dilated Cardiomyopathy
Dysrhythmias V: Evaluating Dysrhythmias
Acute Coronary Syndrome III: Diagnostic Studies

